Browse articles from EyeWorld.org related to steroids. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Positive Phase 3 results in trial investigating topical diabetic macular edema treatment ➤ Positive topline results in Phase 3 trials for retinal vein occlusion treatment ➤ IND filed for drug to treat neuropathic corneal pain ➤ Trial for ‘first-in-class anti-VEGF-complement dual targeting drug’ begins dosing patients ➤ Complimentary access to video journal ➤ ASCRS news and events
➤ Results from Phase 1 clinical trial of intranasal glaucoma drug ➤ Phase 3 clinical trial of new ophthalmic corticosteroid nanoemulsion ➤ Pharmaceutical company expands gene therapy pipeline ➤ Companies enter agreement to develop next-generation decision support software ➤ Study: Association between caffeine intake and glaucoma
Newer steroid and NSAID options (and some off-label administration of antibiotics) that are delivered either via injection or intracanalicular insert can help avoid complicating a patient’s drop regimen that is already subject to non-compliance, instillation issues, potential for ocular surface agitation, and more.
Cataract surgery anti-inflammatory regimens have changed significantly in the last decade, with an emphasis on improving patient compliance.
Patients with herpes simplex virus (HSV) keratitis can present some of the most challenging cases that eye surgeons treat, said Edward J. Holland, M.D., Cincinnati Eye Institute, University of Cincinnati.
As cataract surgery becomes “gentler,” how will a surgeon’s postop treatment strategy change?
Get the latest ophthalmology news delivered to your inbox every Friday.